Julie Ann Justo to Risk Factors
This is a "connection" page, showing publications Julie Ann Justo has written about Risk Factors.
Connection Strength
0.203
-
Adverse reactions associated with systemic polymyxin therapy. Pharmacotherapy. 2015 Jan; 35(1):28-33.
Score: 0.061
-
Evaluation of early clinical failure criteria in Enterococcus species bloodstream infection. Infection. 2022 Aug; 50(4):873-877.
Score: 0.025
-
Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors. J Glob Antimicrob Resist. 2020 09; 22:87-93.
Score: 0.022
-
Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections. Clin Infect Dis. 2019 07 18; 69(3):414-420.
Score: 0.021
-
Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study. Infection. 2018 Aug; 46(4):487-494.
Score: 0.020
-
Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection. 2017 Oct; 45(5):613-620.
Score: 0.018
-
Clinical Risk Score for Prediction of Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates. Infect Control Hosp Epidemiol. 2017 03; 38(3):266-272.
Score: 0.018
-
Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Apr; 60(4):2265-72.
Score: 0.017